Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neural Correlates of Emotional Processing in Depression
NCT00188942Phase 4Completed
- Sponsor
- University Health Network
- Start
- Feb 2005
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fluoxetine and olanzapine in bipolar disorder (BD) and major depressive disorder (MDD) (3 arms), sponsored by University Health Network. Primary endpoints: Functional Magnetic Resonance Imaging Data at 6 weeks, Hamilton Depression Rating Scale 17 Item and 2 more. Started Feb 2005; status: completed.
02
Drugs
fluoxetineolanzapine
03
Conditions
bipolar disorder (BD)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00188942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00188942.